Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer von MOULDER, Stacy L, FRASER SYMMANS, W, ZWIEBEL, James, VALERO, Vicente, HORTOBAGYI, Gabriel N, ESTEVA, Francisco J, BOOSER, Daniel J, MADDEN, Timothy L, LIPSANEN, Cindy, LINDA YUAN, BREWSTER, Abenaa M, CRISTOFANILLI, Massimo, HUNT, Kelly K, BUCHHOLZ, Thomas A

Volltext